Multiple%20Myeloma%20%20

Take Action for Multiple Myeloma Awareness Month

Join our Webinar:

From Multiple Myeloma to
Plasma Cell Myeloma

Dr. Padurean will discuss key multiple myeloma
updates in diagnostic testing for optimal patient care.

Register now

One unified lab advancing cancer care

Welcome to our new look

Comprehensive Sarcoma Dx

Learn more about our Sarcoma Fusion Profiles
with NGS & FISH

Ewing – Non-Ewing – Pediatric Sarcoma
Rhabdomyosarcoma – Liposarcoma

Learn more

No pain. All the gain.

Biopsy-free NeoLAB™ Prostate

An innovative, non-invasive liquid biopsy
test that uses biomarkers in blood and urine,
to assess prostate cancer risk

Learn more

GE Healthcare Biopharma Services

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more 

tradeshow

Upcoming Events

 See our trade show event calendar

Click here to view

March is

Multiple Myeloma

Awareness Month

Learn more

Take action for

Colon Cancer

Awareness Month

Learn more

Image%20Alt%20Text

PD-L1 News for February 2017

PD-L1 22C3 pharmDx replaces lab-developed test (LDT).
Training is required for Tech-only clients

Learn more

NeoGenomics Laboratories
is certified by the

Children’s Oncology Group

Learn more

Image%20Alt%20Text

HER-2 Breast FISH Alternative Assessment

The 2017 January-June self-assessment for our tech-only FISH clients is ready.

Sign into NeoUniversity™

The HPV RNA ISH Panel detects E6/E7 mRNA in 28 HPV subtypes. This test replaces the DNA ISH Panel effective February 27, 2017.

Learn more

HPV RNA ISH Panel

BCR-ABL1 FISH is now available STAT in suspected ALL

Learn more

BCR-ABL1 STAT FISH IN ALL

Targeted next-gen sequencing of clinically relevant mutations in angioimmunoblastic and peripheral T-cell lymphomas

Learn more

NeoTYPE™ AITL/Peripheral T-Cell Lymphoma Profile

NeoLABTM EGFR T790M Liquid Biopsy

Learn more

Accurate and sensitive detection of the EGFR T790M mutation using cell-free plasma DNA

IgH Clonality/MRD by NGS

Quantitative detection of B-lymphocyte clones and heterogeneity suitable for minimal residual disease (MRD) monitoring

Learn more